Today › Pharmaceuticals — injectables › Gland Pharma

Pharmaceuticals — injectables Historical case study · data as of 29 Jul 2026 · published 01 Nov 2026 (95 days later)

Gland Pharma — 100-point case study

How Gland Pharma looked on 50 technical and 50 fundamental measures on 29 Jul 2026 — and what happened over the next three months. Education only; not a current view.

Codes	NSE: GLAND · BSE: 543245
Close on 29 Jul 2026	₹2,543.70
Market cap then	₹41,973 crore
Valuation	P/E 40.9× · P/B 4.05×
Momentum	RSI (14) 63 · 1-year return +21.0%
Next 3 months	+21.7% vs Nifty 50 -4.9% (to 30 Oct 2026)

Scorecard

Technical — 50 points

26 bullish · 18 neutral · 3 caution · 2 bearish — the picture leaned positive.

Fundamental — 50 points

17 bullish · 28 neutral · 2 caution · 2 bearish — the picture leaned positive.

Price chart

Close (to snapshot) Close (after) 50-day avg 200-day avg Support Resistance

Data note: Gland Pharma listed in November 2020, so Screener's annual history starts at FY20 and 10-year growth figures are not available.

Technical analysis — 50 points

Calculated by code from daily prices up to 29 Jul 2026. Standard formulas (RSI, MACD, ADX use Wilder smoothing).

How to read the tags. Each of the 50 points gets one tag. Bullish the reading was favourable. Bearish the reading was unfavourable. Neutral the reading was in a normal range, or gave no clear message. Caution a warning sign or an unusual reading that deserves a closer look. Point 50 counts the other 49 tags. The chart is called positive when bullish tags beat bearish ones by 5 or more, negative when bearish tags beat bullish ones by 5 or more, and mixed otherwise. Under each point you will see what reading earns which tag. Tags describe the data on the snapshot date. They are not signals to buy or sell. Full guide to all 100 points →

A. Trend

#	Point	Reading	Tag	Commentary
1	Short-term trend (20 days)	slope -0.09%/day	Neutral	Over the last 20 sessions the regression line of closing prices was falling about 0.09% a day — a flat, sideways phase. Bullish slope above +0.10% a day (short-term uptrend) · Bearish slope below –0.10% a day (short-term downtrend) · Neutral between the two: a flat, sideways phase.
2	Medium-term trend (~5 months)	3M return +44.5%	Bullish	The 100-session trend line was up (+0.51%/day) and the stock was +44.5% over three months, so the medium-term picture was bullish. Bullish slope above +0.05% a day · Bearish slope below –0.05% a day · Neutral in between.
3	Long-term trend (1 year)	1Y return +21.0%	Bullish	Compared with a year earlier the price was +21.0%. A strong positive year. Bullish up more than 10% in a year · Bearish down more than 10% in a year · Neutral between –10% and +10%.
4	Weekly chart trend	10W 2,361.32 / 30W 1,974.95	Bullish	On the weekly chart the stock showed a weekly close above a rising 10-week and 30-week average stack. Bullish weekly close above the 10-week average, which is above the 30-week · Bearish weekly close below the 10-week average, which is below the 30-week · Neutral when they are tangled.
5	Swing structure (highs/lows)	last highs 2,573.50→2,564.80; lows 2,416.40→2,351.10	Bearish	The two most recent swing points showed lower swing highs and lower swing lows — classic downtrend structure. Bullish higher highs and higher lows (uptrend structure) · Bearish lower highs and lower lows (downtrend structure) · Neutral when one is higher and the other lower.
6	ADX (14) — trend strength	32.5	Bullish	ADX at 32.5 shows a strong trend in force. ADX measures strength only, not direction. Bullish ADX 20 or more with +DI above –DI (a real trend, pointing up) · Bearish ADX 20 or more with –DI above +DI (a real trend, pointing down) · Neutral below 20: no clear trend. 20–30 is a moderate trend, above 30 a strong one.
7	+DI vs –DI	+DI 25.2 / –DI 12.4	Bullish	+DI was above –DI: upward price pressure outweighed downward pressure. Bullish +DI above –DI · Bearish –DI above +DI · No neutral zone for this point.

B. Moving averages

#	Point	Reading	Tag	Commentary
8	Price vs 20-day SMA	2,464.83 (+3.2%)	Bullish	Close of 2,543.70 was 3.2% above the 20-day SMA — the short-term trend filter was positive. Bullish close above the average · Bearish close below the average · No neutral zone.
9	Price vs 50-day SMA	2,355.12 (+8.0%)	Bullish	Close of 2,543.70 was 8.0% above the 50-day SMA — the medium-term trend filter was positive. Bullish close above the average · Bearish close below the average · No neutral zone.
10	Price vs 200-day SMA	1,925.21 (+32.1%)	Bullish	Close of 2,543.70 was 32.1% above the 200-day SMA — the long-term trend filter was positive. Bullish close above the average · Bearish close below the average · No neutral zone.
11	9 / 21 EMA crossover	9E 2,454.20 / 21E 2,431.78	Bullish	The 9-day EMA was above the 21-day EMA; the last crossover happened on 08 Apr 2026. Bullish 9-day above 21-day · Bearish 9-day below 21-day · No neutral zone.
12	Golden / death cross (50 vs 200)	last golden cross 29 May 2026	Bullish	The 50-day average was 22.3% above the 200-day. The most recent signal was a golden cross on 29 May 2026. Bullish 50-day above 200-day (after a “golden cross”) · Bearish 50-day below 200-day (after a “death cross”) · No neutral zone.
13	50-day SMA slope	+12.0% in 20 sessions	Bullish	The 50-day average rose 12.0% over the past month — rising. Bullish rose more than 0.5% · Bearish fell more than 0.5% · Neutral in between: flattening.
14	MA ribbon alignment	2,465 / 2,355 / 2,052 / 1,925	Bullish	The 20/50/100/200-day averages were perfectly stacked bullish (20 > 50 > 100 > 200). Bullish neatly stacked 20 > 50 > 100 > 200 · Bearish neatly stacked 20 < 50 < 100 < 200 · Neutral when tangled (a transition or range).
15	Monthly anchored VWAP	2,479.13 (+2.6%)	Bullish	Anchored to the start of July, the volume-weighted average price was 2,479.13; the close was above it — buyers that month were on average in profit. Bullish close above VWAP (that month’s buyers on average in profit) · Bearish close below VWAP · No neutral zone.

C. Momentum

#	Point	Reading	Tag	Commentary
16	RSI (14)	62.6	Bullish	RSI at 62.6 showed positive momentum without being overbought. Bullish RSI 55–70 (positive momentum, not stretched) · Bearish RSI 30–45 (soft momentum) · Neutral 45–55. Caution at 70 or above (overbought) or 30 or below (oversold).
17	RSI divergence (last 40 days)	bearish divergence	Caution	Comparing the last 20 sessions with the 20 before: bearish divergence: price made a higher high but RSI made a lower high. Bullish bullish divergence: price made a lower low but RSI a higher low · Caution for a bearish divergence (price higher high, RSI lower high). Neutral when RSI moved in line with price.
18	MACD line vs signal	MACD 35.83 / signal 45.86	Bearish	MACD was below its signal line — momentum turning or staying negative. Bullish MACD above signal · Bearish MACD below signal · No neutral zone.
19	MACD histogram (5-day change)	-19.77 → -10.03	Bullish	The histogram rose over the last five sessions, meaning momentum was improving. Bullish histogram rising (momentum improving) · Bearish histogram falling (momentum weakening) · No neutral zone.
20	MACD vs zero line	35.83	Bullish	MACD above zero means the 12-day EMA was above the 26-day EMA — a positive momentum regime. Bullish MACD above zero · Bearish MACD below zero · No neutral zone.
21	Stochastic (14,3,3)	%K 53.5 / %D 33.6	Bullish	Slow stochastic at 53.5 was mid-range with %K above %D. Bullish between 20 and 80 with %K above %D · Bearish between 20 and 80 with %K below %D · Caution above 80 (overbought) or below 20 (oversold).
22	Williams %R (14)	-9.9	Caution	%R of -9.9 put the close near the top of its 14-day range. How to read: Caution above –20 (near the top) or below –80 (near the bottom). Neutral in the middle. This point is never tagged Bullish or Bearish.
23	CCI (20)	93	Neutral	CCI at 93 was within the normal ±100 band. Bullish above +100 (unusually strong upward move) · Bearish below –100 (unusually strong downward move) · Neutral within ±100.
24	Rate of change (10-day)	+3.2%	Bullish	Price changed +3.2% over ten sessions. Bullish up more than 2% · Bearish down more than 2% · Neutral between –2% and +2%.

D. Volatility

#	Point	Reading	Tag	Commentary
25	Bollinger Band position (%B)	%B 0.94 (bands 2,374.69–2,554.97)	Neutral	%B of 0.94 — inside the bands, upper half. How to read: Caution above 1 or below 0 (outside the bands — an overextended move). Neutral inside the bands.
26	Bollinger width / squeeze	width 7.3% (6th pct of 6M)	Caution	Band width was at the 6th percentile of the last six months. A squeeze like this often precedes a larger move (direction unknown). How to read: Caution when the width is in the lowest 15% of six months (a “squeeze” that often comes before a bigger move, direction unknown). Neutral otherwise.
27	ATR (14)	₹81.35 (3.2% of price)	Neutral	A typical day's range was about ₹81.35, or 3.2% of the price — useful for judging how much 'normal noise' to expect. How to read: Information only. A higher % means bigger normal daily swings.
28	Historical volatility (30-day)	33.2% vs 1Y 31.0%	Neutral	Annualised 30-day volatility was 33.2%, close to the one-year level of 31.0%. How to read: Caution when 30-day volatility is more than 1.25× the one-year level. Neutral otherwise.
29	Keltner Channel (20, 2×ATR)	2,273.34–2,596.01	Neutral	The close was inside the channel, so no volatility breakout. Bullish close above the upper channel (strong upward push) · Bearish close below the lower channel · Neutral inside the channel.
30	Beta vs Nifty 50 (1Y daily)	0.62	Neutral	A beta of 0.62 means the stock tended to move less than the Nifty 50 day to day. How to read: Information only. Above 1.1 moves more than the market, below 0.9 less, around 1 in line.

E. Volume & money flow

#	Point	Reading	Tag	Commentary
31	Volume vs 20-day average	last day 1.72× / 5-day 0.67×	Neutral	The final session traded 1.72× its 20-day average volume and the last five sessions averaged 0.67× — lighter than usual participation. How to read: Information only. Above 1.2× is heavier than usual participation, below 0.8× lighter.
32	Up-day vs down-day volume (20d)	ratio 0.97	Neutral	Average volume on up days was 0.97× that on down days — balanced. Bullish ratio above 1.15 (accumulation-leaning) · Bearish ratio below 0.85 (distribution-leaning) · Neutral between 0.85 and 1.15.
33	On-Balance Volume (20d)	OBV rising	Bullish	OBV rose over the month while price rose — volume confirmed the price move. Bullish OBV rising · Bearish OBV falling · No neutral zone.
34	Accumulation/Distribution line	rising (20d)	Bullish	The A/D line rose, meaning closes tended to be in the upper part of daily ranges on meaningful volume. Bullish A/D line rising · Bearish A/D line falling · No neutral zone.
35	Chaikin Money Flow (20)	0.07	Bullish	CMF at +0.07 indicated net inflows. Bullish above +0.05 (net inflows) · Bearish below –0.05 (net outflows) · Neutral between –0.05 and +0.05.
36	Money Flow Index (14)	54.9	Neutral	MFI, a volume-weighted RSI, was 54.9. Bullish MFI 55–80 · Bearish MFI 20–45 · Neutral 45–55. Caution above 80 (overbought) or below 20 (oversold).
37	Liquidity (avg daily turnover)	₹121 cr/day	Neutral	About ₹121 crore changed hands per day on average over 20 sessions — liquid. How to read: Information only. Above ₹500 crore a day is highly liquid, above ₹50 crore liquid, below that moderately liquid.

F. Price levels

#	Point	Reading	Tag	Commentary
38	Support levels (S1/S2/S3)	2,416.40 / 2,351.10 / 2,181.90	Neutral	Nearest support (prior swing lows) sat at 2,416.40, 5.3% below the close, then 2,351.10, 2,181.90. How to read: Information only. Levels to watch, not good or bad.
39	Resistance levels (R1/R2/R3)	2,555.53	Neutral	Nearest resistance (prior swing highs) sat at 2,555.53, 0.5% above the close. How to read: Information only.
40	Monthly pivot points (for next month)	P 2,489.43 \| R1 2,627.77 \| S1 2,405.37	Neutral	Classic pivots from July's high/low/close gave a pivot of 2,489.43; the close was above it. How to read: Information only.
41	Fibonacci retracement (6M swing)	23.6% 2,338 \| 38.2% 2,192 \| 50.0% 2,074 \| 61.8% 1,956	Neutral	Measuring the 6-month rise from 1,573.60 to 2,573.50, the close was nearest the 23.6% retracement at 2,337.52. How to read: Information only.
42	52-week high / low	H 2,573.50 / L 1,573.60	Bullish	The close was 1.2% below the 52-week high and 61.6% above the 52-week low. Bullish within 5% of the 52-week high · Bearish within 5% of the 52-week low · Neutral in between.
43	Unfilled price gaps (6M)	1 open; latest gap-up 18 May at 1,950.00	Neutral	There was 1 unfilled gap(s). The latest, a gap-up on 18 May 2026, left an open level at 1,950.00 that price had not revisited. How to read: Information only.

G. Patterns

#	Point	Reading	Tag	Commentary
44	Price structure / chart pattern	pullback inside a larger uptrend	Neutral	Rule-based pattern scan: pullback inside a larger uptrend. (Classical patterns like head-and-shoulders are judgement calls; we report only what the rules detect.) Bullish rising channel (both trends up) · Bearish falling channel (both trends down) · Neutral for tight consolidation, a bounce in a downtrend, a pullback in an uptrend, or a sideways range.
45	Breakout / breakdown (20-day)	range 2,351.10–2,573.50	Neutral	The close was inside the prior 20-day range of 2,351.10–2,573.50. Bullish close above the 20-day high (breakout) · Bearish close below the 20-day low (breakdown) · Neutral inside the range.
46	Latest candlestick	Bullish marubozu-type candle	Bullish	On 29 Jul the candle opened 2,428.70, ranged 2,428.70–2,550.00 and closed 2,543.70: Bullish marubozu-type candle. Single candles are weak signals on their own. Bullish hammer, bullish engulfing or bullish marubozu · Bearish shooting star, bearish engulfing or bearish marubozu · Neutral for a doji, inside bar or ordinary candle. Single candles are weak signals.
47	Ichimoku Cloud	cloud 2,034.00–2,203.10; Tenkan 2,450.55 / Kijun 2,379.25	Bullish	Price was above the cloud and the Tenkan line was above the Kijun line — a bullish Ichimoku setup. Bullish close above the cloud · Bearish close below the cloud · Neutral inside the cloud.

H. Relative strength & summary

#	Point	Reading	Tag	Commentary
48	Relative strength vs Nifty 50	1M +0.3% / 3M +43.4%	Bullish	The stock outperformed the Nifty 50 by 43.4 points over three months and outperformed by 0.3 points over one month. Bullish ahead of the Nifty 50 by more than 2 points · Bearish behind by more than 2 points · Neutral within ±2 points.
49	Relative strength vs Nifty 50 (6M)	6M +53.9%	Bullish	No sector index in today's data set, so we show the 6-month comparison instead: 53.9 points ahead of the Nifty 50. Bullish ahead by more than 2 points · Bearish behind by more than 2 points · Neutral within ±2 points.
50	Technical summary	26 bullish · 2 bearish · 18 neutral · 3 caution	Bullish	Across the 49 readings the technical picture leaned positive. Levels that mattered: support 2,416.40, resistance 2,555.53. This is a description of the chart on 29 Jul 2026, not a forecast. How to read the score: the strongest possible reading is 49 bullish · 0 bearish, and the weakest is 0 bullish · 49 bearish. Most companies land in between. The chart is called positive when bullish tags beat bearish ones by 5 or more, negative when bearish tags beat bullish ones by 5 or more, and mixed otherwise. Even a 49–0 score describes the past and is not a reason to buy, and a 0–49 score is not a reason to sell. Bullish bullish tags beat bearish ones by 5 or more (“positive”) · Bearish bearish tags beat bullish ones by 5 or more (“negative”) · Neutral (“mixed”) otherwise. Strongest possible: 49 bullish · 0 bearish.

Fundamental analysis — 50 points

Uses only results published by 29 Jul 2026: FY26 annual (Apr 2025–Mar 2026), the Jan–Mar 2026 quarter and the Jun 2026 shareholding. ₹ crore, consolidated unless stated. Valuation uses the 29 Jul 2026 close.

How to read the tags. Each of the 50 points gets one tag. Bullish the reading was favourable. Bearish the reading was unfavourable. Neutral the reading was in a normal range, or gave no clear message. Caution a warning sign or an unusual reading that deserves a closer look. Point 50 counts the other 49 tags. The numbers are called positive when bullish tags beat bearish ones by 4 or more and are at least 1.5 times as many, negative the other way round, and mixed otherwise. Under each point you will see what reading earns which tag. Tags describe the data on the snapshot date. They are not signals to buy or sell. Full guide to all 100 points →

A. Valuation

#	Point	Reading	Tag	Commentary
1	P/E (trailing 12 months)	40.9×	Neutral	At ₹2,543.70 the market valued the company at about ₹41,973 crore, or 40.9× the ₹1,027 crore profit of the four quarters to Mar 2026. That is a premium multiple — the market expected growth. How to read: Information only. Below 15 is a low multiple, 15–30 moderate, above 30 a premium (the market expects growth). Compare with peers and the company’s own history.
2	Price / Book	4.05×	Neutral	Market cap was 4.05× the Mar 2026 book value (equity + reserves) of ₹10,357 crore. How to read: Information only. Main yardstick for banks; asset-light businesses usually trade at high P/B.
3	Price / Sales	6.53×	Neutral	The company was valued at 6.53× its trailing-12-month sales of ₹6,431 crore. How to read: Information only.
4	EV / EBITDA (approx.)	25.9×	Neutral	Enterprise value (market cap + ₹284 cr borrowings; cash not netted) was 25.9× trailing operating profit of ₹1,630 crore. How to read: Information only. Lower means cheaper relative to operating profit.
5	Earnings yield	2.4%	Neutral	The inverse of P/E: each ₹100 invested bought about ₹2.4 of annual earnings. Investors often compare this with the ~6–7% yield on 10-year government bonds. How to read: Information only. Often compared with the ~6–7% yield on 10-year government bonds.
6	PEG (P/E ÷ 3-yr profit CAGR)	4.28	Bearish	P/E of 40.9 divided by 3-year profit growth of 9.6% a year gives a PEG of 4.28. Below 1 is often read as growth being cheaply priced; above 2 as expensive. Note: revenue jumped more than 40% in Mar 2024, which usually signals a merger or acquisition — multi-year growth rates are inflated by it. Bullish below 1 (growth cheaply priced) · Bearish above 2 (growth expensively priced) · Neutral 1–2, or when profit did not grow (not meaningful).
7	Dividend yield (trailing 12M)	0.71%	Neutral	Dividends with ex-dates in the 12 months to the snapshot totalled ₹18 a share, a 0.71% yield on the ₹2,543.70 price. Bullish above 3% · Neutral at 3% or less. Never tagged Bearish.
8	Market capitalisation	₹41,973 cr	Neutral	At about ₹0.42 lakh crore the company was a mid-cap. How to read: Information only. Above ₹1 lakh crore large-cap, ₹30,000 crore–₹1 lakh crore mid-cap, below that small-cap (our rule of thumb).
9	Graham number vs price	₹937.55 vs ₹2,543.70	Neutral	Benjamin Graham's conservative fair-value yardstick √(22.5 × EPS × book value per share) came to ₹937.55; the price was 171% above it. Quality franchises usually trade above this number. Bullish price below the Graham number · Neutral when the price is above it (most quality companies are).

B. Growth

#	Point	Reading	Tag	Commentary
10	Revenue growth FY26 (YoY)	+14.5%	Bullish	Revenue for FY26 was ₹6,431 crore, +14.5% versus FY25. Bullish above 10% · Bearish below 0% (revenue fell) · Neutral 0–10%.
11	Q4 FY26 revenue growth (YoY)	+22.3%	Bullish	The Jan–Mar 2026 quarter brought ₹1,743 crore of revenue, +22.3% on the same quarter a year earlier. Bullish above 10% · Bearish below 0% · Neutral 0–10%.
12	Net profit growth FY26 (YoY)	+46.9%	Bullish	FY26 net profit was ₹1,027 crore, +46.9% on FY25's ₹699 crore. Bullish above 10% · Bearish below 0% · Neutral 0–10%. Caution if a one-off item distorted the figure.
13	Q4 FY26 profit growth (YoY)	+96.3%	Bullish	Quarterly profit was ₹367 crore versus ₹187 crore a year earlier (+96.3%). Bullish above 10% · Bearish below 0% · Neutral 0–10%.
14	Revenue CAGR (3 years)	21.1%	Caution	Revenue compounded at 21.1% a year from FY23 to FY26. Note: revenue jumped more than 40% in Mar 2024, which usually signals a merger or acquisition — multi-year growth rates are inflated by it. Bullish above 12% a year · Bearish below 5% a year · Neutral 5–12%. Caution if an acquisition inflated it.
15	Profit CAGR (3 years)	9.6%	Neutral	Net profit compounded at 9.6% a year from FY23 to FY26. Note: revenue jumped more than 40% in Mar 2024, which usually signals a merger or acquisition — multi-year growth rates are inflated by it. Bullish above 12% a year · Bearish below 5% a year · Neutral 5–12%.
16	Revenue CAGR (5 years)	13.2%	Caution	Over five years (FY21–FY26) revenue compounded at 13.2% a year. Note: revenue jumped more than 40% in Mar 2024, which usually signals a merger or acquisition — multi-year growth rates are inflated by it. Bullish above 12% a year · Bearish below 5% a year · Neutral 5–12%.
17	EPS growth FY26 (reported)	+47.1%	Bullish	Reported EPS went from ₹42.40 to ₹62.35 (+47.1%). Differences from profit growth come from changes in share count (bonus, buyback, new issues). Bullish above 10% · Bearish below 0% · Neutral 0–10%.

C. Profitability

#	Point	Reading	Tag	Commentary
18	Operating margin FY26	25%	Neutral	Operating profit (EBITDA) was 25% of sales in FY26 versus 23% in FY25. How to read: Information only — normal margins differ a lot by industry.
19	Operating margin trend (4 quarters)	24% → 21% → 26% → 29%	Bullish	Quarterly margins moved from 24% to 29% over the last four quarters — expanding. Bullish up more than 1 percentage point · Bearish down more than 1 percentage point · Neutral when broadly stable.
20	Net profit margin FY26	16.0%	Neutral	₹16.0 of every ₹100 of revenue ended up as net profit in FY26. How to read: Information only.
21	Return on equity FY26	10.5%	Neutral	FY26 profit was 10.5% of average shareholders' equity. Above ~15% is generally considered good; below 10% weak. Bullish above 18% · Bearish below 10% · Neutral 10–18%. Around 15% or more is generally considered good.
22	ROCE FY26	15%	Neutral	Return on capital employed (debt + equity) was 15% in FY26. Bullish above 20% · Bearish below 10% · Neutral 10–20%.
23	Return on assets FY26	8.25%	Neutral	Net profit was 8.25% of total assets. Bullish banks only: 1.5% or more · Bearish banks only: below 1% · Information only for non-banks.
24	Effective tax rate FY26	30%	Neutral	The company paid about 30% of pre-tax profit as tax; India's base corporate rate is ~25%. How to read: Information only. India’s base corporate rate is about 25%.
25	Other income share of pre-tax profit	20%	Neutral	Non-operating 'other income' of ₹292 crore made up 20% of pre-tax profit. How to read: Caution above 25% (headline profit leans on non-core income). Neutral otherwise.

D. Balance sheet

#	Point	Reading	Tag	Commentary
26	Debt / equity	0.03	Bullish	Borrowings of ₹284 crore were 0.03× equity — very low leverage. Bullish below 0.3 (very low leverage) · Bearish above 1 (high leverage) · Neutral 0.3–1.
27	Debt / EBITDA	0.17×	Bullish	Debt equalled 0.17 years of FY26 operating profit. Bullish below 1× · Bearish above 3× · Neutral 1–3×.
28	Interest coverage	45.4×	Bullish	Earnings before interest and tax covered interest cost 45.4 times. Bullish above 8× · Bearish below 3× · Neutral 3–8×, or not meaningful when interest is negligible.
29	Book value growth	+13.2%	Bullish	Shareholders' equity grew +13.2% from ₹9,150 crore to ₹10,357 crore in FY26. Bullish above 10% (banks: above 12%) · Bearish below 0% (non-banks only) · Neutral otherwise.
30	Capital work in progress	₹342 cr (8% of fixed assets)	Neutral	Projects under construction (CWIP) were 8% of fixed assets — a modest pipeline. How to read: Information only. Above 20% means a big expansion pipeline that is not yet earning.
31	Working capital days	145 days	Neutral	Working capital tied up equalled 145 days of sales (FY25: 173). Negative means suppliers/customers fund operations. How to read: Information only. Lower is generally more efficient; negative means suppliers or customers fund the business.
32	Cash conversion cycle	255 days	Neutral	It took 255 days to turn inventory and receivables into cash, net of supplier credit. How to read: Information only. Shorter is generally better.
33	Debtor days	107 (FY25 99)	Neutral	Customers took 107 days on average to pay, versus 99 a year earlier. How to read: Caution when debtor days rose more than 20% in a year (collections stretching). Neutral otherwise.

E. Cash flow

#	Point	Reading	Tag	Commentary
34	Operating cash flow FY26	₹1,031 cr	Bullish	The business generated ₹1,031 crore of operating cash in FY26 versus ₹915 crore in FY25. Bullish positive and higher than the year before · Bearish negative · Neutral when positive but lower. Information only for banks.
35	Free cash flow FY26	₹538 cr	Bullish	After capital spending, free cash flow was ₹538 crore. Bullish positive · Bearish negative · Neutral when not available.
36	Cash conversion (CFO ÷ net profit)	1.00×	Bullish	Operating cash flow was 1.00× reported profit — profits were well backed by cash. Bullish above 1× (profits well backed by cash) · Caution below 0.7×. Neutral 0.7–1×.
37	Free-cash-flow yield	1.3%	Neutral	FY26 free cash flow was 1.3% of the snapshot market cap. Bullish above 4% · Neutral at 4% or less.
38	Free cash flow — 3-year total	₹1,658 cr	Bullish	Free cash flow over FY24–FY26 added up to ₹1,658 crore. Bullish positive total · Bearish negative total · Neutral when not available.
39	Capex FY26 (CFO – FCF)	₹493 cr	Neutral	Implied capital expenditure was about ₹493 crore, 7.7% of sales. How to read: Information only.

F. Dividends & shareholder returns

#	Point	Reading	Tag	Commentary
40	Dividend payout ratio FY26	32%	Neutral	The company paid out about 32% of FY26 profit as dividends. How to read: Information only. High payout suits mature businesses; growing firms often keep more.
41	Dividend consistency (3 years)	43% / 42% / 32%	Bullish	Payout ratios for FY24 / FY25 / FY26 — dividends were paid every year. Bullish paid every year · Neutral when irregular. Never tagged Bearish.
42	Share capital change (FY25→FY26)	+0.0%	Neutral	Paid-up equity capital changed +0.0% (₹16 cr → ₹16 cr). Essentially unchanged — no dilution. Bullish fell 1% or more (a buyback) · Caution when it rose 1% or more (new shares issued). Neutral when unchanged, or for a bonus/split.

G. Ownership

#	Point	Reading	Tag	Commentary
43	Promoter holding	51.77% (-0.06 pts YoY)	Neutral	Promoters owned 51.77% at Jun 2026 versus 51.83% a year earlier. Bearish fell more than 1 percentage point in a year · Neutral otherwise. Never tagged Bullish.
44	Foreign institutional holding	8.74% (+1.35 pts YoY)	Bullish	FIIs held 8.74% at Jun 2026, up from 7.39% a year before. Bullish up more than 1 percentage point · Bearish down more than 1 percentage point · Neutral within ±1 point.
45	Domestic institutional holding	30.44% (-2.42 pts YoY)	Bearish	Mutual funds, insurers and other DIIs held 30.44%, down from 32.86%. Bullish up more than 1 percentage point · Bearish down more than 1 percentage point · Neutral within ±1 point.
46	Number of shareholders	1.1 lakh (-2.2% YoY)	Neutral	The shareholder count moved from 1.1 lakh to 1.1 lakh in a year — a rough gauge of retail interest. How to read: Information only — a rough gauge of retail interest.
47	Promoter pledge	n/a	Neutral	No pledge figure for the snapshot date in our sources. Screener page shows no pledged-shares information. How to read: Information only. Any sizeable pledge is a risk to note.

H. Quality & summary

#	Point	Reading	Tag	Commentary
48	Financial health checklist (Piotroski-style, 8 tests)	8/8	Bullish	Passed: positive profit, positive operating cash flow, CFO > net profit, leverage fell, operating margin improved, ROA improved, asset turnover improved, no meaningful dilution (<3%). Bullish all tests passed, or all but one · Bearish half the tests or fewer passed · Neutral in between.
49	Automated screen flags	2 strength(s) · 3 weakness(es)	Neutral	Strengths: Company is almost debt free; Company has been maintaining a healthy dividend payout of 39.1%. Weaknesses: Stock is trading at 4.92 times its book value; Promoter holding has decreased over last quarter: -6.02%; Company has a low return on equity of 9.29% over last 3 years. (Flags generated by the data source’s rule screen.) How to read: Information only.
50	Fundamental summary	17 bullish · 2 bearish · 28 neutral · 2 caution	Bullish	On the numbers published by 29 Jul 2026 the fundamental picture leaned positive. Valuation: P/E 40.9×, P/B 4.05×. This describes the data, not a recommendation. How to read the score: the strongest possible reading is 49 bullish · 0 bearish, and the weakest is 0 bullish · 49 bearish. Most companies land in between. The numbers are called positive when bullish tags beat bearish ones by 4 or more and are at least 1.5 times as many, negative the other way round, and mixed otherwise. Even a 49–0 score describes the past and is not a reason to buy, and a 0–49 score is not a reason to sell. Bullish bullish tags beat bearish ones by 4 or more and are at least 1.5× as many (“positive”) · Bearish the same the other way round (“negative”) · Neutral (“mixed”) otherwise. Strongest possible: 49 bullish · 0 bearish.

News in the three months before the snapshot

Company news from 29 Apr 2026 – 29 Jul 2026 that an investor could have known on the snapshot date.

15 May 2026 Gland Pharma Q4 FY26: revenue up 22%, adjusted PAT up 97%; Rs 20 final dividend recommended — Q4 FY26 revenue from operations was Rs 17,428 million (up 22% YoY), EBITDA Rs 5,130 million (up 48%) and adjusted PAT Rs 3,667 million (up 97%). The board recommended a final dividend of Rs 20 per share. source
18 May 2026 Gland Pharma shares jump 16% to 52-week high on Q4; analysts retain 'Buy' — The stock rose as much as 16.22% to a 52-week high of Rs 2,170 on BSE after Q4 results. Motilal Oswal said revenue, EBITDA and PAT beat its estimates by 8%, 25% and 40%. source
18 May 2026 Gland Pharma fixes August 11, 2026 as record date for Rs 20 final dividend — The Rs 20 per share final dividend for FY26 is subject to shareholder approval at the AGM, with record date fixed as August 11, 2026. source
29 Jul 2026 Gland Pharma gets USFDA approval for generic Sugammadex (Bridion) injection — Gland received final USFDA approval for Sugammadex Injection 200 mg/2 mL and 500 mg/5 mL vials, a generic of Merck's Bridion, whose US sales were about $1.6 billion in the 12 months to April 2026 (IQVIA). The product was launched through a marketing partner on the day of approval. source

What happened next (29 Jul 2026 → 30 Oct 2026)

Price went from ₹2,543.70 to ₹3,095.90 by 30 Oct 2026 (+21.7%) while the Nifty 50 moved -4.9% — outperforming by 26.6 points.
Highest ₹3,171.00 on 07 Oct 2026; lowest ₹2,493.00 on 30 Jul 2026.
S1 2,416.40: held on a closing basis.
S2 2,351.10: held on a closing basis.
R1 2,555.53: cleared on a closing basis on 03 Aug 2026.
200-day SMA: price was above it at the snapshot and stayed on the same side through the period.
Apr–Jun 2026 results (reported 10 Aug 2026): revenue ₹1,800 crore (+19.5% YoY), net profit ₹317 crore (+47.4% YoY), operating margin 27% vs 24% a year earlier (Screener consolidated figures).

Later news

10 Aug 2026 Gland Pharma Q1 FY27: net profit up 47% to Rs 317 crore; CDMO 50% of revenue — Consolidated net profit rose to Rs 317 crore from Rs 215 crore and revenue from operations rose 19.5% to Rs 1,800 crore; EBITDA margin was 27.16%. The company also announced a CDMO partnership with a global pharma company with estimated annual revenue potential of about $90-100 million once commercialised. source
11 Aug 2026 Gland Pharma rallies 12%, stock hits 4-year high post Q1 results — Shares rose sharply on August 11 after the Q1 FY27 results; the same day was the ex/record date for the Rs 20 final dividend. source
03 Sep 2026 Gland Pharma's Visakhapatnam facilities clear USFDA inspection with zero Form 483 observations — The USFDA inspected the VSEZ sterile oncology formulations facility and API facility in Visakhapatnam from August 24 to September 1, 2026, and the inspection concluded with zero Form 483 observations. source
06 Sep 2026 Promoter Fosun Pharma sells stake in Gland Pharma via block deals; holding falls below 50% — Fosun Pharma sold 4.55% (75.05 lakh shares) on BSE block deals on Friday (September 4) at an average Rs 2,826.60 for Rs 2,121.5 crore, cutting its holding to 47.22% from 51.77%. Screener shows promoter holding at 45.75% for the September 2026 quarter. source
05 Oct 2026 Gland Pharma to invest $21 million in US subsidiary to acquire 60% of Novelstar Pharma — At its October 1, 2026 board meeting, Gland approved investing $21 million in proposed subsidiary Gland Pharma USA to acquire 60% of newly incorporated Novelstar Pharma Inc; Fosun Pharma USA will hold the other 40%. source
24 Oct 2026 Gland Pharma receives 4 USFDA observations for Dundigal formulation facility — A USFDA inspection of the Dundigal formulation facility from October 12 to October 23, 2026 ended with four Form 483 observations. source

Educational summary. On 29 Jul 2026 the technical picture leaned positive and the fundamental picture leaned positive. Over the next three months the stock moved +21.7% against -4.9% for the Nifty 50. Here the chart's message lined up with what followed. One case proves nothing on its own; the value is in seeing many cases over time. This page does not say whether to buy, sell or hold Gland Pharma today.

Method designed by our founder, CPA · ACCA · CIA. Numbers are computed by our engine from the sources listed below.

Sources: daily prices — Yahoo Finance history pages; financials and shareholding — Screener.in (fetched 01 Nov 2026); index — Nifty 50 via Yahoo Finance; news — linked articles. Calculations by Manage Our Finance. Report a correction

More case studies today

₹225.56close 29 Jul

Engineering consultancy (PSU)NSE: ENGINERSINData as of 29 Jul 2026

Engineers India — 100-point case study

Technical

Fundamental

What happened next (3 months): +11.7% vs Nifty 50 -4.9%

Technical: negativeFundamental: positiveP/E 18.3×P/B 4.03×RSI 421Y +4.2%

₹984.90close 29 Jul

Cables & wiresNSE: FINCABLESData as of 29 Jul 2026

Finolex Cables — 100-point case study

Technical

Fundamental

What happened next (3 months): +15.7% vs Nifty 50 -4.9%

Technical: negativeFundamental: positiveP/E 21.1×P/B 2.48×RSI 401Y +8.4%

₹293.58close 29 Jul

IT-enabled services (BPM)NSE: FSLData as of 29 Jul 2026

Firstsource Solutions — 100-point case study

Technical

Fundamental

What happened next (3 months): -0.2% vs Nifty 50 -4.9%

Technical: positiveFundamental: positiveP/E 30.8×P/B 4.73×RSI 731Y -11.0%